magnifying glass
logo for Sesen Bio

Sesen Bio

Get Full Access

Description

Sesen Bio, Inc. is a late-stage clinical company advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The Company's lead pr... Read More

Headquarters

Headquarters:

245 1st St, Ste 1800, Cambridge, Massachusetts, 02142, United States
Phone

Phone:

(617) 444-8550
Employees

Employees:

<25
Revenue

Revenue:

$8 Million
Sesen Bio's Social Media
SIC Code 28,283
NAICS Code 32541,325
Popular Searches:

Sesen Bio Inc

Sesen Bio , Inc.

Sesen Bio

Sesen Bio Inc.

Sesen Bio.

Sesen Bio's Org Chart

Thomas Cannell
Thomas Cannell

President & Chief Executive Officer

PhonePhoneEmailEmail
Monica Forbes
Monica Forbes

Chief Financial Officer

PhonePhoneEmailEmail
Glen MacDonald
Glen MacDonald

Chief Technology Officer

PhonePhoneEmailEmail

PhonePhoneEmailEmail

PhonePhoneEmailEmail
Illustration of an envelope

Sesen Bio's Tech Stack

Adobe Activation

By

Adobe

Google Global Site Tag

By

Google

Office 365

By

Microsoft

Fastly

By

Fastly

Drupal

By

Drupal

Google Font API

By

Google
See more technologies

Sesen Bio News & Media

Sesen Bio Further Enhances Team with Key Hires

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced the appointments of Minori Rosales, M.D., Ph.D. as Chief Development Officer as of January 24, 2022 and Stephanie Vigue as Director of Finance as of January 17, 2022. “We are pleased to welcome these highly qualified new employees to our team,” said Dr. Thomas Cannell, president and chief executive o

Sesen Bio Announces Anticipated Regulatory Path Forward for Vicineum™

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio (Nasdaq:SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced its anticipated regulatory path forward for Vicineum™ for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) following its Clinical Type A meeting with the US Food and Drug Administration (FDA), which occurred on December 8, 2021 (Clinical Type A Meeting). Following the produ
Subscribe to "Sesen Bio" News

Frequently Asked Questions regarding Sesen Bio

Where are Sesen Bio’s headquarters?

Sesen Bio’s headquarters are in 245 1st St, Ste 1800, Cambridge, Massachusetts, 02142, United States

What is Sesen Bio’s phone number?

Sesen Bio’s phone number is (617) 444-8550

What is Sesen Bio’s official website?

Sesen Bio’s official website is //www.sesenbio.com

What is Sesen Bio’s Revenue?

Sesen Bio’s revenue is $8 Million

What is Sesen Bio’s SIC code?

Sesen Bio’s SIC: 28,283

What is Sesen Bio’s NAICS code?

Sesen Bio’s NAICS: 32541,325

How many employees are working in Sesen Bio?

Sesen Bio has <25 employees

What is Sesen Bio’s industry?

Sesen Bio is in the industry of: Drug Manufacturing & Research, Pharmaceuticals, Healthcare

What is Sesen Bio's tech stack?

The technologies that are used by Sesen Bio are: Adobe Activation, Google Global Site Tag, Office 365, Fastly

Who is Sesen Bio's CEO?

Sesen Bio's CEO is Thomas Cannell

Who is Sesen Bio's CFO?

Sesen Bio's CFO is Monica Forbes

Who is Sesen Bio's CTO?

Sesen Bio's CTO is Glen MacDonald

See more information about Sesen Bio

Browse ZoomInfo’s Directories